SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Trading Update

30 Jun 2014 07:00

RNS Number : 8336K
McBride PLC
30 June 2014
 



30th June 2014

 

McBride PLC

Trading Update

 

McBride PLC, Europe's leading provider of Private Label Household and Personal Care products, today provides an update on trading for the year ended 30th June 2014 prior to entering its close period, and is also communicating an update with regard to the strategic review of its UK business.

 

The Board expects to report adjusted operating profit and net debt for the year just ended in line with its expectations indicated by the previous trading statement.

 

Group full year revenue on a constant currency basis is expected to show a decline of 3% as previously announced. Private Label revenue was flat with continued growth in our France/Benelux, Poland and Germany businesses, the latter driven by significant new business wins, offset by the effects of the weak retail environment in the UK and Italy and continued increased branded promotional activity. Contract revenue declined by 20% as expected due to the winding down of certain contracts.

 

As previously announced, and in response to a deterioration in the retail environment in UK, the Board is conducting a wide-ranging strategic review of its UK business. The Board is today announcing further opportunities to restructure the Group's activities, remove un-profitable business and reduce capacity in the UK in order to improve profitability. Savings of around £12 million are expected to be delivered in full by June 2016 with around £3 million benefitting FY15. Associated cash implementation costs are expected to be around £14 million. Regrettably, it is expected that, of a workforce of 1,600 in the UK business, around 400 positions are expected to be made redundant. Consultation with affected employee groups will start immediately.

 

As a consequence of the review, the Board expects to impair the value of assets in UK by £21 million, including £6 million of goodwill, in the current financial year.

 

In addition, the Group expects to incur material one-off costs in relation to two matters. The implementation of the European Classification, Labelling and Packaging regulations will lead to exceptional costs of around £4m as a consequence of the need to re-configure the labelling of almost all the Group's products. The Group is also expected to take an exceptional charge of £2.5m in relation to a long term environmental remediation plan at a site in Belgium.

 

For the 2015 year, underlying growth in Group revenue of 2% is expected, although this will be offset by the exiting of un-profitable business as part of the UK re-structuring. Net debt at June 2015 is expected to be in the range £105 million to £110 million, leaving significant headroom within the Group's borrowing facilities. Total exceptional charges will amount to around £37 million in FY14 and £7 million in FY15, including the impairment noted above and final costs in relation to existing savings programmes.

 

The Group intends to announce its preliminary results for the year ended 30th June 2014 on 10th September 2014.

 

Chris Bull, Group Chief Executive Officer, commented:

 

"We are announcing a robust plan that will help restore our UK profitability. We will exit some business in non-core un-profitable categories, but our capacity to meet growth opportunities in our core categories remains unaffected. We will be entering into full and meaningful consultation with colleagues affected by these proposals".

 

 

For further information please contact:

 

McBride plc

Chris Bull, Chief Executive

020 3642 1587

Richard Armitage, Group Finance Director

020 3642 1587

FTI Consulting

Ed Bridges, Nick Hasell

020 3727 1017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBKLLLZQFBBBZ
Date   Source Headline
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:05 amRNSInterim results for 6M ended 31 December 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.